Table 3.
Embolism and thromboembolic, gastrointestinal perforation and major cardiovascular adverse events related to JAK inhibitors.
Significant values are given in bold.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.